Denmark· DK-28107475325
Levocetirizindihydrochlorid Carefarm
A levocetirizine product containing levocetirizindihydrochlorid, registered in Denmark by Orifarm A/S. The same ATC class is registered in 16 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Levocetirizine is registered in 16 of 19 countries.
Countries holding a registration under ATC R06AE09 (levocetirizine), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 10 of them publish a price we can compare per daily dose
Levocetirizine · ATC R06AE09
16 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of levocetirizine costs, country by country.
Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.15 in France to $0.53 in Switzerland — a ×3.4 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Levocetirizine · price per daily dose (5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.53
- ES Spain$0.34
- IT Italy$0.21
- FR France$0.15
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Levocetirizindihydrochlorid
- Manufacturer
- Orifarm A/S
- Country
- Denmark (DK)
- ATC code
- R06AE09
- ATC class
- Levocetirizine
- Defined daily dose
- 5 mg, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28107475325
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
267 interactions on record for levocetirizine.
Graded by severity as the source publishes them — 264 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Levocetirizine · interactions on record
267 records
- 264 moderate
- 3 minor
Most severe, free to view
- MetoclopramideA03FA01moderate
- DimenhydrinatA04AB02moderate
- ThiethylperazinA04AB03moderate
- DiphenhydraminA04AB05moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under R06AE09
Levocetirizine, as other registers publish it.
- United States24HR Allergy ReliefLEADER/ Cardinal Health 110, Inc.
- PolandAlcetyrArtespharm Sp. z o.o.
- PolandAlergimedDr. Max Pharma s.r.o.
- CzechiaALERGIMEDMEDREG s.r.o., Praha
- CzechiaALERGIMEDMEDREG s.r.o., Praha
- CzechiaALERGIMEDMEDREG s.r.o., Praha
- CzechiaALERGIMEDMEDREG s.r.o., Praha
- CzechiaALERGIMEDMEDREG s.r.o., Praha
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f519b7ef-b927-4017-a455-335a245fbb82 GET /v1/drugs/f519b7ef-b927-4017-a455-335a245fbb82?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "filmovertrukne tabletter",
"source": "dkma",
"strength": "5 mg",
"auth_role": "DKMA",
"dk_drugid": "28107475325",
"substance": "Levocetirizindihydrochlorid",
"auth_procedure": "Par-Imp",
"in_medicinpriser": false,
"registration_date_serial": "46010"
}See everything about levocetirizine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.